Please login to the form below

Not currently logged in
Email:
Password:

genomics

This page shows the latest genomics news and features for those working in and with pharma, biotech and healthcare.

AZ and CRUK launch Cambridge genomics centre

AZ and CRUK launch Cambridge genomics centre

The new partnership representation an expansion in its ambitions, and access to CRUK's world class functional genomics database will facilitate faster progress. ... The announcement was made just days after Genomics England hit its target of sequencing

Latest news

More from news
Approximately 13 fully matching, plus 121 partially matching documents found.

Latest Intelligence

  • Deal Watch October 2018

    treatments based on functional genomics discovery. platform. Strategic. collaboration. $1.75B. SQZ Biotech/. ... Gilead has paid $50m upfront to gain access to Tango’s functional genomics‐based discovery platform, for which it has options on up to

  • The future of medicine has to be data-driven The future of medicine has to be data-driven

    Employing data-driven medicine will allow us to create cohorts of patients with similar characteristics including the genomic profile of their tumours. ... The rapid adoption of genomic testing powered by AI in recent years illustrates the faith in this

  • The critical role of science in healthcare communications The critical role of science in healthcare communications

    Entirely new fields of medicine are emerging, such as human genomics and precision therapies that are tailor-made for the individual based on specific genome sequencing.

  • Communication is the key to unlocking the potential of immuno-oncology Communication is the key to unlocking the potential of immuno-oncology

    The science of ‘omics’ – genomics, proteomics, metabolomics – has already taught us that the Big C is far from a singular entity, but is more like thousands of individual diseases caused by

  • Can new data aggregators shift the balance of power away from pharma? Can new data aggregators shift the balance of power away from pharma?

    However, it was only 20 years ago that several genomics companies, led by Human Genome Sciences Inc, thought they could secure a monopoly position over unprecedented drug targets by filing patents ... As it turned out the central dogma was too simplistic;

More from intelligence
Approximately 4 fully matching, plus 31 partially matching documents found.

Latest appointments

More from appointments
Approximately 3 fully matching, plus 19 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 5 fully matching, plus 15 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Market Study Report

Market Study Report is a hub for market intelligence products and services. We streamline the purchase of your market research...

Latest intelligence

AstraZeneca’s oncology renaissance
Susan Galbraith played a key role in restoring AstraZeneca’s place in cancer drug development – she talks about the future of oncology and why there’s more to be done to...
Navigating the antibiotic resistance crisis
Blue Latitude Health speaks to Tara DeBoer, PhD, Postdoctoral Researcher and CEO of BioAmp Diagnostics to explore the antimicrobial resistance crisis, and learn how a simple tool could support physicians...
Combined immunotherapies – potential and pitfalls
‘Combining therapeutic compounds is the first logical step towards better results, namely higher rates of patients responding to treatment, with deeper and more sustained responses’...

Infographics